We aimed to identify tumor antigens from autoantibodies identified prior to palpable tumors in two mouse mammary tumor models (TgMMTV-neu and C3(1)Tag), that were involved in survival of HER2 positive and triple negative human breast cancer cell lines as they could be effective immunogens in breast cancer vaccines. The gene discussed is ERBB2; the disease is neoplasm.